Johnson Financial Group »

Enanta Pharmaceuticals shares owned by Johnson Financial Group

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Johnson Financial Group from 13F filings

Historical chart of Johnson Financial Group investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Johnson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Johnson Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3k 188 11.97

More positions owned by Johnson Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Johnson Outdoors Cl A (JOUT)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Msci Acwi Ex Us (ACWX)
Ishares Tr Core Msci Total (IXUS)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Johnson Financial Group

Top funds holding Enanta Pharmaceuticals

Farallon Capital Management
Krensavage Asset Management
Henderson Group
Vanguard Group
BlackRock
Millennium Management
Acadian Asset Management
Commodore Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Stonepine Capital Management
Point72 Asset Management
Morgan Stanley
Marshall Wace

View all funds holding Enanta Pharmaceuticals